XML 41 R81.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Stock-Based Compensation Plans Stock Performance Rights (Details) - USD ($)
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Stock Performance Rights    
Accrued Employee Benefits, Current $ 14,908,000 $ 13,458,000
Valuation assumptions:    
Allocated Share-based Compensation Expense 100,000 100,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Share-based Liabilities Paid 13,400,000 100,000
Weighted Average Exercise Price    
MSU Expense $ 1,200,000 1,200,000
Stock Performance Rights    
Stock Performance Rights    
Weighted average estimated value of SPRs outstanding (per share) $ 25.34  
Valuation assumptions:    
Expected volatility, minimum, percent 32.10%  
Expected volatility, maximum, percent 40.70%  
Risk-free rate of return, minimum 1.60%  
Risk-free rate of return, maximum 1.70%  
Expected annual dividend $ 0.00  
Allocated Share-based Compensation Expense $ 14,900,000 $ 4,800,000
Number of SPRs    
Outstanding on December 31, 2018 958,521  
Granted 26,825  
Exercised (379,567)  
Cancelled (5,918)  
Outstanding on December 31, 2019 599,861 958,521
Exercisable on December 31, 2019 523,084  
Weighted Average Exercise Price    
Outstanding on December 31, 2018 $ 26.56 $ 19.75
Granted   30.78
Exercised   9.65
Cancelled   27.15
Outstanding on December 31, 2019   26.56
Exercisable on December 31, 2019   $ 26.50
SPRs outstanding, intrinsic value $ 15,300,000  
Total unrecognized compensation cost $ 1,000,000  
Unrecognized cost, period for recognition 1 year 2 months 12 days  
Exercised 47,779  
Vested in period, fair value $ 1,400,000  
Weighted average remaining contractual term, SPRs outstanding 3 years  
Weighted average remaining contractual term, SPRs exercisable 2 years 6 months  
Stock Performance Rights | Minimum    
Stock Performance Rights    
Life of award 7 years  
Award vesting period   1 year
Valuation assumptions:    
Expected term 6 months  
Stock Performance Rights | Maximum    
Stock Performance Rights    
Award vesting period 3 years  
Valuation assumptions:    
Expected term 4 years 6 months